Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 435.05
+0.70 (0.16%)
At close: Feb 16, 2026
Syngene International Employees
Syngene International had 6,533 employees as of March 31, 2025. The number of employees increased by 23 or 0.35% compared to the previous year.
Employees
6,533
Change (1Y)
23
Growth (1Y)
0.35%
Revenue / Employee
5.69M INR
Profits / Employee
538.96K INR
Market Cap
173.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6,533 | 23 | 0.35% |
| Mar 31, 2024 | 6,510 | -337 | -4.92% |
| Mar 31, 2023 | 6,847 | 872 | 14.59% |
| Mar 31, 2022 | 5,975 | 538 | 9.90% |
| Mar 31, 2021 | 5,437 | 491 | 9.93% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Alembic Pharmaceuticals | 16,571 |
| Divi's Laboratories | 10,542 |
| Piramal Pharma | 5,476 |
| NATCO Pharma | 4,199 |
| Sai Life Sciences | 3,401 |
Syngene International News
- 20 days ago - Syngene International shares fall sharply over 7% today: Details here - Business Upturn
- 24 days ago - Syngene International Ltd (BOM:539268) Q3 2026 Earnings Call Highlights: Navigating Revenue ... - GuruFocus
- 24 days ago - Q3 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 4 weeks ago - Syngene International extends strategic collaboration with Bristol Myers Squibb Till 2035 - Business Upturn
- 2 months ago - Syngene International Ltd Webinar on Clinical Trials Market Call Transcript - GuruFocus
- 3 months ago - Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 3 months ago - Q2 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Goldman Sachs maintains buy on Syngene, bullish on FY26 early-teens growth outlook, sees 15.5% upside on Q1 beat and rising CRO-led margin gains - Business Upturn